Generics News
-
Lupin receives FDA approval for generic Lodosyn tablets and Kapvay Extended-Release tablets
Generics | News | 0 Comment | 27 Oct, 2017
Pharma Major Lupin has announced that it has received final approval for its Carbidopa Tablets, 25 mg and Clonidine Hydrochloride Extended-Release Tablets, 0.1 mg from the United States Foo...Read more
-
US FDA approves Bydureon BCise by AstraZeneca for type-2 diabetes
Generics | News | 0 Comment | 23 Oct, 2017
Biopharma company AstraZeneca has announced its US Food and Drug Administration (FDA) approved Bydureon BCise (exenatide extended-release) injectable suspension. The new for...Read more
-
NCD: A major public health challenge for Asia-Pacific
Generics | News | 0 Comment | 11 Oct, 2017
Incidence of non-communicable diseases (NCDs) is on the rise, globally as well as in Asia Pacific region. Implications are far reaching too – while on one hand, it results in a loss o...Read more
-
Lupin receives FDA approval for generic Corgard Tablets
Generics | News | 0 Comment | 10 Oct, 2017
Pharma Major Lupin has announced that it has received final approval for its Nadolol Tablets USP, 20 mg, 40 mg, and 80 mg from the United States Food and Drug Administration (FDA) to market...Read more
-
"Biomarkers can play a key role in improving diagnosis and disease management of heart failure. "
Generics | Opinion | 0 Comment | 10 Oct, 2017
Singapore - Southeast Asia is home to 9 million heart failure patients. In Singapore alone, it accounts for around 6,000 hospitalizations. Worryingly, not only is heart failure prevalence o...Read more
-
Arthritis: Act before it gets Late
Generics | News | 0 Comment | 13 Sep, 2017
Started in 1996, October 12 is recognised as the World Arthritis Day (WAD). Established by Arthritis and Rheumatism International (ARI) and supported by the European League Against Rheumati...Read more
-
Michigan third most preferred destination in Midwest for life science investment
Generics | News | 0 Comment | 11 Sep, 2017
Michigan ranked third among 11 Midwest regions for the value of equity investments made in life sciences companies during the first half of 2017. A midyear report from Cleveland-base...Read more
-
Eli Lilly to invest more in new medicines and drive growth
Generics | News | 0 Comment | 08 Sep, 2017
Eli Lilly and Company has decided to streamline operations to more efficiently focus resources on developing new medicines and to improve its cost structure. Global workforce reductions, in...Read more
-
Lupin launches generic Benicar tablets in the US
Generics | News | 0 Comment | 04 Sep, 2017
Pharma company Lupin Limited has announced the launch of its Olmesartan Medoxomil tablets, 5 mg, 20 mg and 40 mg having received an approval from the United States Food and Drug Administrat...Read more
-
U.S. FDA approves chemo group's benznidazole to treat children with Chagas disease
Generics | News | 0 Comment | 01 Sep, 2017
Singapore – The U.S. Food and Drug Administration (FDA) approved Chemo Research's New Drug Application (NDA) for benznidazole. This is the first drug ever approved by the FDA to treat...Read more
-
Battlefield Acupuncture (BFA): New pain management process for the military
Generics | News | 0 Comment | 27 Aug, 2017
Singapore - With the pressing need for more efficient and agile pain management practices for military service personnel, Dr. Richard C. Neimtzow of Andrews Air force base d...Read more
-
Victoza indicated to reduce the risk of three major adverse cardiovascular events
Generics | News | 0 Comment | 26 Aug, 2017
The U.S. Food and Drug Administration (FDA) has approved a new indication for Victoza (liraglutide) to reduce the risk of major adverse cardiovascular (CV) events, heart attack, stroke...Read more
-
Generic Seroquel XR tablets launched by Lupin in USA
Generics | News | 0 Comment | 24 Aug, 2017
Lupin Limited has announced the launch of its Quetiapine Fumarate Extended-Release Tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg. The tablet was approval from the United States Food an...Read more
-
Generics | News | 0 Comment | 21 Aug, 2017
Singapore – US FDA has granted two orphan drug designations (ODD) for T cell therapy products to Singapore-based biotech company, Lion TCR Pte Ltd, for the treatment of hepatocel...Read more
-
FDA provides new tools for tests to detect Zika virus infection
Generics | News | 0 Comment | 18 Aug, 2017
Singapore- As an additional measure in the fight against Zika virus, today the U.S. Food and Drug Administration announced that it has made available a panel of human plasma samples to aid ...Read more
-
Bruker announces US FDA clearance of expanded 3rd claim for MALDI Biotyper
Generics | News | 0 Comment | 01 Aug, 2017
Singapore – Bruker, a US based manufacturing company of scientific instruments announced that it has received US Food & Drug Administration (FDA) clearance for its third, further ...Read more
-
LEO Pharma gets EC nod for its first and only biologic Kyntheum that targets the IL-17 receptor
Generics | News | 0 Comment | 26 Jul, 2017
LEO Pharma announced that the European Commission has granted marketing authorization for Kyntheum (brodalumab), a new biologic for the treatment of moderate-to-severe plaque psoriasis in a...Read more
-
Merck wins tentative U.S. FDA approval for Lusduna
Generics | News | 0 Comment | 26 Jul, 2017
Merck announced in a press release that the U.S. Food and Drug Administration (FDA) has granted tentative approval for LUSDUNA Nexvue (insulin glargine injection) 100 units/mL, a ...Read more
